purpos
studi
evalu
viral
frequenc
season
clinic
demograph
featur
patient
hospit
acut
bronchiol
crosssect
descript
studi
perform
infant
younger
year
age
hospit
acut
viral
bronchiol
respiratori
tract
infect
agent
investig
polymeras
chain
reaction
pcr
total
infant
includ
studi
infant
least
one
respiratori
tract
pathogen
detect
respiratori
syncyti
viru
rsv
common
viru
identifi
infant
follow
rhinoviru
n
studi
viral
agent
determin
via
pcr
patient
followedup
due
diagnosi
acut
bronchiol
rsv
detect
common
agent
studi
almost
half
rsvposit
patient
rsv
accompani
second
third
agent
acut
bronchiol
ab
common
acut
lower
respiratori
system
diseas
infant
often
caus
viral
infect
especi
lead
caus
hospit
infant
month
age
epidem
peak
ab
frequent
seen
winter
season
respiratori
syncyti
viru
rsv
usual
caus
case
virus
includ
adenoviru
influenza
viru
parainfluenza
viru
also
report
caus
ab
sole
pathogen
coinfect
without
rsv
variou
polymeras
chain
reaction
pcr
techniqu
possibl
new
agent
like
rhinoviru
human
metapnomoviru
human
bocaviru
bordatella
pertussi
atyp
pathogen
also
describ
lead
caus
ab
cardiovascular
diseas
chronic
pulmonari
diseas
immunodefici
prematur
birth
increas
risk
abassoci
respiratori
failur
even
death
world
health
organ
report
rsv
caus
pathogen
million
new
acut
lower
respiratori
infect
episod
children
year
age
give
rise
million
hospit
admiss
death
everi
year
diagnosi
ab
made
base
typic
histori
wheez
characterist
clinic
featur
tachypnea
nasal
flare
chest
retract
wheez
andor
rale
follow
viral
upper
respiratori
infect
infant
american
academi
pediatr
aap
chest
radiograph
laboratori
studi
may
thought
clinic
suspicion
evalu
differenti
diagnosi
secondari
comorbid
bacteri
infect
complic
condit
viral
diagnosi
method
includ
antigen
detect
immunofluoresc
nasal
secret
wash
nasal
aspir
rapid
antigen
test
pcr
suggest
identifi
specif
viral
agent
children
bronchiol
result
determin
discontinu
palivizumab
prophylaxi
initi
continuationdiscontinu
antibiot
therapi
major
studi
recent
research
burden
respiratori
viral
tract
infect
agent
ab
larger
group
studi
epidemiolog
clinic
risk
factor
ab
also
defin
said
ab
frequent
infanc
increas
number
admiss
hospit
bronchiolitisrel
morbid
purpos
studi
evalu
frequenc
pathogen
determin
differ
clinic
microbiolog
featur
among
patient
month
age
hospit
ab
ege
univers
children
hospit
ege
univers
children
hospit
tertiari
care
pediatr
teach
hospit
hospit
locat
heavili
popul
area
izmir
serv
nearli
inpati
per
year
mostli
middl
low
socioeconom
statu
studi
approv
institut
review
board
ege
univers
children
hospit
conduct
period
prospect
crosssect
studi
children
younger
month
hospit
ab
conduct
octob
octob
gener
pediatr
ward
children
hospit
ethic
committe
ege
univers
approv
studi
infant
hospit
ab
recruit
inform
written
parent
consent
accord
recommend
aap
guidelin
diagnosi
ab
base
least
follow
sign
chest
retract
tachypnea
wheez
rale
auscult
follow
viral
upper
respiratori
tract
infect
children
less
month
age
first
time
exclud
infant
hospit
within
week
current
admiss
develop
nosocomi
ab
known
histori
bronchopulmonari
dysplasia
chronic
lung
diseas
congenit
heart
diseas
immunodefici
infant
born
prematur
also
exclud
studi
detail
demograph
data
includ
age
gender
smoke
exposur
epidemiolog
data
collect
structur
questionnair
medic
file
patient
admiss
hospit
admiss
clinic
paramet
sever
diseas
includ
wheez
retract
respiratori
rate
gener
situat
evalu
assess
wang
respiratori
score
paramet
given
point
child
point
ad
describ
sever
ab
point
show
mild
bronchiol
moder
point
indic
sever
bronchiol
complet
blood
count
white
blood
cell
count
percentag
lymphocyt
creactiv
protein
measur
admiss
nasal
smear
obtain
infant
test
presenc
rsv
influenza
viru
type
b
adenoviru
parainfluenza
virus
human
rhinoviru
human
coronaviru
human
metapneumoviru
human
bocaviru
multiplex
reversetranscript
pcr
method
realaccur
respiratori
rt
pcr
pathofind
netherland
seeplex
ace
detect
seegen
south
korea
nasal
sampl
obtain
commonli
nurs
sometim
research
assist
subject
within
hour
admiss
use
standard
protocol
sampl
frozen
transport
ice
depart
clinic
microbiolog
virolog
laboratori
univers
viral
nucleic
acid
amplif
data
analys
perform
use
spss
version
quantit
data
includ
percentag
mean
standard
deviat
calcul
simpl
descript
analys
mean
sd
use
summar
demograph
data
baselin
characterist
case
analys
conduct
use
spss
spss
inc
chicago
il
april
april
total
infant
hospit
ab
includ
prospect
studi
mean
age
month
male
tabl
frequent
age
rang
infant
ab
month
account
includ
case
patient
cough
runni
nose
admiss
hospit
nearli
half
infant
diagnos
ab
expos
passiv
smoke
histori
atopi
infant
tabl
show
clinic
data
laboratori
find
diseas
sever
score
hospit
rate
durat
hospit
infant
common
complaint
patient
cough
fever
present
case
admiss
hospit
examin
percentag
infant
wheez
ninetysix
infant
need
oxygen
supplement
mean
length
hospit
durat
day
half
infant
moder
bronchiol
mean
respiratori
score
acut
bronchiol
diagnos
infant
younger
month
age
overal
least
one
respiratori
viru
detect
case
ege
univers
children
hospit
result
incid
respiratori
virus
infant
hospit
ab
studi
period
shown
tabl
rsv
identifi
infant
hospit
ab
rsv
common
agent
rsvposit
infant
sole
pathogen
rsv
infant
rsvcoinfect
respons
respiratori
tract
infect
second
preval
viral
agent
rhinoviru
identifi
subject
singl
pathogen
quadrupl
infect
detect
infant
multipl
agent
rsv
case
common
viru
follow
rhinoviru
n
influenza
viru
n
human
metapneumoviru
n
piv
n
adenoviru
n
human
bocaviru
n
parainfluenza
viru
n
human
coronaviru
n
among
dual
coinfect
combin
rsv
rhinoviru
highest
number
n
age
distribut
infant
shown
figur
rsv
rhinoviru
adenoviru
dual
infect
particular
viral
agent
identifi
children
month
wherea
rsv
detect
infant
age
month
n
n
rsvposit
infant
age
year
age
case
patient
monthli
incid
bronchiol
infant
due
common
respiratori
pathogen
shown
figur
major
case
admit
hospit
winter
time
peak
occur
januari
februari
march
detect
rate
also
high
month
respect
respiratori
viru
epidem
seen
also
winter
season
figur
fifteen
case
infect
parainfluenza
viru
adenoviru
human
bocaviru
seen
summer
time
current
studi
infant
hospit
bronchiol
prove
ab
import
caus
hospit
infant
mostli
younger
month
age
use
multiplex
realtim
pcr
techniqu
demonstr
least
one
respiratori
viral
pathogen
respons
bronchiol
case
variou
studi
shown
rsv
common
etiolog
pathogen
rate
almost
case
relat
virus
includ
adenoviru
coronaviru
parainfluenza
influenza
rhinoviru
recent
year
new
human
respiratori
virus
like
human
metapneumoviru
human
bocaviru
new
human
coronavirus
also
report
possibl
pathogen
caus
ab
today
variou
viral
diagnost
test
allow
us
examin
epidemiolog
differ
clinic
characterist
respiratori
virus
provid
inform
presenc
multiplex
pcr
commonli
use
method
due
signific
advantag
like
permit
simultan
amplif
sever
virus
singl
reaction
facilit
costeffect
diagnosi
studi
evalu
via
multiplex
pcr
techniqu
varieti
burden
viral
agent
caus
ab
infant
month
age
find
agreement
result
sever
studi
previous
report
rsv
diagnos
infant
admit
hospit
acut
bronchiol
rsv
common
viru
identifi
infant
studi
stempel
et
al
show
rsv
incid
antun
et
al
found
rsv
epidem
season
studi
rsv
frequent
identifi
respiratori
viru
account
respiratori
virus
addit
infant
studi
posit
rhinoviru
follow
influenza
viru
human
metapneumoviru
adenoviru
human
bocaviru
parainfluenza
viru
human
coronaviru
human
rhinovirus
common
human
respiratori
pathogen
respons
upper
respiratori
infect
eg
common
cold
may
also
caus
sever
lower
respiratori
tract
infect
includ
pneumonia
bronchiol
addit
human
rhinovirus
known
major
pathogen
asthma
exacerb
children
adult
recent
studi
shown
rhinovirus
second
commonli
seen
pathogen
ab
studi
conduct
unit
state
found
preval
rhinoviru
similar
studi
howev
studi
report
lower
incid
rate
human
rhinovirus
acut
bronchiol
studi
show
respiratori
viral
agent
exhibit
season
pattern
number
rsv
rhinoviru
case
peak
winter
season
similar
alreadi
publish
previou
studi
report
season
distribut
respiratori
agent
may
occur
due
meteorolog
condit
spread
infecti
pathogen
pathogen
transmiss
host
behavior
due
differ
meteorolog
condit
anoth
import
theori
pathogen
activ
total
sunshin
exposur
hypothes
ultraviolet
light
radiat
could
affect
spread
rsv
inactiv
citi
izmir
turkey
locat
west
mediterranean
climat
summer
hot
dri
winter
warm
raini
climat
featur
could
explain
season
pattern
respiratori
virus
studi
keep
previou
studi
found
respiratori
virus
could
occur
coinfect
respiratori
virus
within
rang
dual
tripl
dual
frequent
ong
et
al
show
studi
rsv
bronchiol
associ
pathogen
present
infant
multicent
studi
report
coinfect
rate
studi
papadopoulo
et
al
state
infant
dualinfect
rsv
togeth
rhinoviru
studi
identifi
coinfect
infant
bronchiol
half
show
dual
combin
report
mortal
infant
less
year
age
diagnos
bronchiol
born
prematur
underli
cardiopulmonari
diseas
immunodefici
today
mortal
rate
ab
low
due
fact
infant
monitor
prevent
measur
palivizumab
improv
health
servic
howev
increas
number
infant
appli
hospit
hospit
hall
et
al
report
yearli
incid
hospit
due
rsv
bronchiol
infant
age
month
emerg
depart
visit
offic
visit
per
children
studi
number
limit
first
investig
hospit
patient
acut
bronchiol
infant
appli
emerg
servic
outpati
policlin
studi
group
small
number
second
identifi
possibl
agent
atyp
bacteri
pathogen
could
caus
acut
bronchiol
third
studi
period
adequ
compar
longterm
studi
studi
show
caus
agent
acut
bronchiol
quit
vari
inpati
infant
ege
univers
children
hospit
period
year
molecular
diagnost
techniqu
uncov
high
frequenc
virus
viral
combin
infect
among
patient
hospit
ab
rsv
remain
frequent
caus
pathogen
follow
rhinoviru
even
result
diagnost
method
rsv
show
common
pathogen
singl
multipl
viral
infect
also
consid
ab
present
studi
also
emphas
potenti
signific
virus
influenza
viru
human
metapneumoviru
adenoviru
human
bocaviru
parainfluenza
viru
human
coronaviru
infant
hospit
acut
bronchiol
sole
copathogen
